ZAFRENS
Zafrens is a drug discovery company that develops life sciences products that allow full characterization of diverse cell populations. The company's platform specializes in generating insights at the interface of biology, chemistry, and engineering. The company was founded in 2021 and is headquartered in San Diego, California, United States.
ZAFRENS
Social Links:
Industry:
Biotechnology Chemical Engineering Life Science
Founded:
2021-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.zafrens.com
Total Employee:
11+
Status:
Active
Contact:
(215) 796-0147
Total Funding:
29 M USD
Technology used in webpage:
Squarespace Hosted
Similar Organizations
MapLight Therapeutics
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Conagen
Conagen, a biotechnology company that focuses on bio-production of ingredients for food, pharmaceutical, and renewable materials industries.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
nference
nference is an Artificial Intelligence (AI)-powered venture creation engine
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Prime Movers Lab
Prime Movers Lab investment in Series A - Zafrens
BlueYard Capital
BlueYard Capital investment in Series A - Zafrens
Global Brain Corporation
Global Brain Corporation investment in Series A - Zafrens
Iaso Ventures
Iaso Ventures investment in Series A - Zafrens
Alix Ventures
Alix Ventures investment in Series A - Zafrens
KOFA Healthcare Investments
KOFA Healthcare Investments investment in Series A - Zafrens
Possible Ventures
Possible Ventures investment in Series A - Zafrens
Hawktail Management
Hawktail Management investment in Series A - Zafrens
FoundersX Ventures
FoundersX Ventures investment in Series A - Zafrens
Liquid 2 Ventures
Liquid 2 Ventures investment in Seed Round - Zafrens
Official Site Inspections
http://www.zafrens.com Semrush global rank: 11.71 M Semrush visits lastest month: 150
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Zafrens"
About 1 - Zafrens
At its core Zafrens is an attempt to harness opportunities at the intersection of technical disciplines. To this end we specialize in forging autonomous, high-performing, mission …See details»
Zafrens - Crunchbase Company Profile & Funding
Zafrens is a drug discovery company that develops life sciences products that allow full characterization of diverse cell populations. The company's platform specializes in generating insights at the interface of biology, chemistry, and …See details»
Zafrens - LinkedIn
Zafrens is a therapeutics company pioneering an ultra-high throughput platform to isolate, culture, image, and sequence millions of cells per day.See details»
Zafrens Inc. Company Profile | San Diego, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Zafrens Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Zafrens, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
About Zafrens Zafrens is pioneering an ultra-high throughput platform to isolate, culture, image, and sequence millions of cells per day. The proprietary platform allows for full characterization …See details»
Zafrens Company Profile 2024: Valuation, Funding
Zafrens General Information Description. Developer of life-sciences products designed to generate insights at the interface of biology, chemistry, and engineering. The company offers a resolution approach to studying cell-drug …See details»
Zafrens - Funding, Financials, Valuation & Investors - Crunchbase
Zafrens offers a throughput platform for cell characterization, correlating molecular profiles to phenotype for accelerated drug discovery. ... How much funding has this organization raised …See details»
Zafrens - Crunchbase
Organization. Zafrens . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Zafrens offers a platform for accelerated drug …See details»
Zafrens - VentureRadar
At Zafrens we are building novel tools that allow us to connect the functional behavior of millions of individual cells to their underlying (multiomic) molecular profiles. ... Dansk Biotek Unknown …See details»
Zafrens - Company Profile & Staff Directory - ContactOut
We are a lifesciences products company specializing in building tools and generating insights at the interface of biology, chemistry and engineering. We work extensively in cellular analysis …See details»
Zafrens - possible.ventures
Zafrens exists to bring the life sciences to the AI era using cutting edge engineering tools. The costs and pace of data generation in biology/chemistry lag behind our ability to process data …See details»
Zafrens - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Zafrens offers a throughput platform for cell characterization, correlating molecular profiles to phenotype for accelerated drug discovery.See details»
Zafrens Launches with $23M in Financing to Advance Multiple …
SAN DIEGO, December 11, 2023--Zafrens Launches with $23M in Financing to Advance Multiple Stages of Drug Discovery in a Single Experiment at Unprecedented ScaleSee details»
Mitsui Chemicals invests in drug discovery company ‘Zafrens’
Dec 15, 2023 Mitsui Chemicals announced that it has invested in Zafrens, a company supporting drug discovery through high-throughput single-cell analysis, via 321FORCE Global Innovation …See details»
Zafrens Launches with $23M in Financing to Advance Multiple …
Dec 11, 2023 Zafrens is pioneering an ultra-high throughput platform to isolate, culture, image, and sequence millions of cells per day. The proprietary platform allows for full characterization …See details»
Zafrens Launches with $23M in Financing to Advance ... - Financial …
Dec 11, 2023 The Z-Screen ™ is a step-change in throughput and resolution of experiments, expanding the conventional 96-well format to 50,000 – 200,000 wells with imaging and single …See details»
Technology - Zafrens
Zafrens. Technology About Open Menu Close Menu. Technology About Resolution . scale and connections. Conventional cell profiling methods reveal vignettes - never the whole narrative . …See details»
Zafrens - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Zafrens . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Zafrens has 2 current employee profiles, including …See details»
Zafrens - Alix Ventures
Zafrens “Zafrens is developing an ultra-high throughput single cell platform to isolate, image, run assays on, and sequence millions of individual single cells per day. This platform allows for full …See details»